Share of the population living with HIV receiving antiretroviral therapy in North Macedonia

North Macedonia: Share of the population living with HIV receiving antiretroviral therapy was 59.1% in 2024. ◆ Volatile

Latest (2024)
59.1%
Change on year
up 5.0%
World rank
113th
of 149 countries
All-time high
59.1%
in 2024
All-time low
0.0%
in 1992
Years of data
32
1992–2024

Share of the population living with HIV receiving antiretroviral therapy in North Macedonia, 1992–2024

02040601992200820241992: 0 %1993: 0 %1994: 0 %1995: 0 %1997: 2.6 %1998: 3.7 %1999: 5 %2000: 6.5 %2001: 8.1 %2002: 8 %2003: 9.4 %2004: 3 %2005: 9.4 %2006: 13.1 %2007: 15.9 %2008: 20.1 %2009: 17.5 %2010: 21.8 %2011: 22.9 %2012: 26.3 %2013: 28 %2014: 30.1 %2015: 37.2 %2016: 41.4 %2017: 43.7 %2018: 48.4 %2019: 49.4 %2020: 52.9 %2021: 52.5 %2022: 53.5 %2023: 56.3 %2024: 59.1 %

Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.

Analysis

North Macedonia recorded 59.1% for share of the population living with hiv receiving antiretroviral therapy in 2024. That is the highest value across all 32 years on record.

The figure is up 5.0% on the previous year and up 96.5% over ten years.

Over the whole period, share of the population living with hiv receiving antiretroviral therapy in North Macedonia peaked at 59.1% in 2024 and was at its lowest, 0.0%, in 1992.

North Macedonia ranks 113th of 149 countries on this measure, in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Share of the population living with HIV receiving antiretroviral therapy in North Macedonia, year by year

Annual values for Share of the population living with HIV receiving antiretroviral therapy in North Macedonia, 1992 to 2024.
Year % Change
1992 0.0% —
1993 0.0% —
1994 0.0% —
1995 0.0% —
1997 2.6% —
1998 3.7% +38.8%
1999 5.0% +35.5%
2000 6.5% +30.9%
2001 8.1% +24.4%
2002 8.0% -0.9%
2003 9.4% +16.8%
2004 3.0% -68.5%
2005 9.4% +219.6%
2006 13.1% +38.5%
2007 15.9% +21.5%
2008 20.1% +26.5%
2009 17.5% -12.9%
2010 21.8% +24.3%
2011 22.9% +5.1%
2012 26.3% +15.0%
2013 28.0% +6.4%
2014 30.1% +7.6%
2015 37.2% +23.5%
2016 41.4% +11.5%
2017 43.7% +5.6%
2018 48.4% +10.7%
2019 49.4% +2.1%
2020 52.9% +7.1%
2021 52.5% -0.9%
2022 53.5% +1.9%
2023 56.3% +5.3%
2024 59.1% +5.0%

North Macedonia compared with similar countries

  • North Macedonia's 59.1% is below the median for upper middle income countries, which is 65.5%, 90% of the median. (43 countries reporting)
  • North Macedonia's 59.1% is below the median for Europe & Central Asia, which is 82.9%, 71% of the median. (34 countries reporting)

Biggest year-on-year movements

Years where Share of the population living with HIV receiving antiretroviral therapy in North Macedonia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2005 +219.6% 3.0% 9.4%

Averages by decade

DecadeAverage LowestHighest Years
1990s 1.6% 0.0% 5.0% 7
2000s 11.1% 3.0% 20.1% 10
2010s 34.9% 21.8% 49.4% 10
2020s 54.9% 52.5% 59.1% 5

Countries ranked near North Macedonia

  1. 110 Malaysia 60.4% compare
  2. 111 Barbados 60.4% compare
  3. 112 Bolivia 59.7% compare
  4. 114 Palestine 58.4% compare
  5. 115 Paraguay 58.3% compare
  6. 116 Venezuela 56.6% compare

See the full ranking of 149 places →

More reference data data for North Macedonia

All data for North Macedonia →

Frequently asked questions

What is share of the population living with hiv receiving antiretroviral therapy in North Macedonia?
Share of the population living with hiv receiving antiretroviral therapy in North Macedonia was 59.1% in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in North Macedonia?
The highest recorded value was 59.1% in 2024.
What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in North Macedonia?
The lowest recorded value was 0.0% in 1992.
How does North Macedonia rank for share of the population living with hiv receiving antiretroviral therapy?
North Macedonia ranks 113th out of 149 countries with data for 2024.
Is share of the population living with hiv receiving antiretroviral therapy rising or falling in North Macedonia?
Over the last ten years it is up 96.5%. The long-run trend across the full record is volatile.
Where does this North Macedonia data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 32 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of the population living with HIV receiving antiretroviral therapy in North Macedonia. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Retrieved 29 September 2026, from https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/north-macedonia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/north-macedonia/">Share of the population living with HIV receiving antiretroviral therapy in North Macedonia</a> — Statizoid

About this data

Indicator
Share of the population living with HIV receiving antiretroviral therapy
Unit
%
Source
Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
149 places, 5,062 data points, 1990–2024
Last refreshed

Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.